Journal
CHEMICAL COMMUNICATIONS
Volume 51, Issue 81, Pages 14981-14984Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c5cc05412e
Keywords
-
Categories
Funding
- King's College London
- Biotechnology and Biological Sciences Research Council [BB/J008656/1]
- Wellcome Trust [WT103913MF]
- Atomic Energy Commission of Syria
- Engineering and Physical Sciences Research Council [EP/I014470/1] Funding Source: researchfish
- BBSRC [BB/J008656/1] Funding Source: UKRI
- EPSRC [EP/I014470/1] Funding Source: UKRI
Ask authors/readers for more resources
Azide-and alkyne-double functionalised graphene oxide (Click(2) GO) was synthesised and characterised with attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR), thermogravimetric analysis (TGA) and Raman spectroscopy. Fourteen-percentage increase in azide content was found, after pre-treatment of GO with metachloroperoxybenzoic acid (mCPBA), determined with elemental analysis. No effect on A549 cell viability was found, up to 100 mu g mL(-1) and 72 h of incubation, determined with the modified lactate dehydrogenase (mLDH) assay. Two sequential copper(I) catalysed azide-alkyne cycloaddition (CuAAC) reactions were performed to conjugate the propargylmodified blood-brain barrier targeting peptide Angiopep-2, and a bis-azide polyethylene glycol (M-W = 3500), to the Click(2) GO. The final conjugate was characterised with ATR-FTIR and TGA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available